DUNTON ALAN W bought OGEN
December 11, 2025 · Form 4 insider transaction
DUNTON ALAN W bought 125,000 shares of Oragenics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderDUNTON ALAN W
RoleDirector
CompanyOragenics, Inc. (OGEN)
SecurityNon-Employee Director Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.